Feline oral squamous cell carcinoma (FOSCC) is a devastating cancer that too many pet cats suffer from each year. Current therapies do not provide more than an average of 3 months survival time, and new treatments are desperately needed. My research focus for my PhD is on targeted therapy for FOSCC with a novel anti-cancer agent that specifically works by targeting certain enzymes that are found in this cancer type.